MUC1 and cancer: Additionally, KL-6 was found to modulate a range of pathways implicated in cancer progression, including cell cycle, ferroptosis, apoptosis, and epithelial-mesenchymal transition (EMT)-associated pathways such as focal adhesion and tight junction as illustrated in Fig. 4A.